Obelis expands monthly plan offering to include greater round-the-clock client support and EU regulatory consulting scope.
Webinars and events
Biocompatibility: MDR and EN ISO 10993-1:2018
What does the new standard on Medical Device Regulation say.
Obelis visiting Cosmoprof Las Vegas
The Obelis team visited Last Vegas in July 2018 to deepen relationships with clients, work on upcoming projects, and attend Cosmoprof North America.
Challenges When Designing a Mobile Medical App for Safe and Effective Use
As application designers have begun taking advantage of the advancements of technology and the growing patient trend for self-diagnosis and treatment, regulators have begun scrutinizing mobile medical apps.
Obelis visits Tokyo!
The Obelis team visited Tokyo in May 2018 to develop relationships with clients and attend Beautyworld Japan, one of Japan's top cosmetics industry shows.
Efficacy and Safety Claims: testing cosmetic products
Understanding claims criteria and best practices for cosmetics products according to EU cosmetics regulation 655/2013: guidelines, compliance points, and more.
How to select a Notified Body?
Working with a notified body is a mandatory obligation under the EU new approach directives. But how do you select the right one for your devices? We can help.
Obelis at Medica 2016
Obelis Group exhibited for the 13th consecutive year at Medica Trade Fair, one of the…
Obelis to hold EROMED seminar at MEDICA 2016
Obelis Group will hold an EROMED seminar at the MEDICA trade show, taking place from the 14th November till 17th November in Messe Düsseldorf, in Germany. The seminar, which is entirely free of charge, will be conducted at the Obelis booth (Hall 17, Stand D59), every day at 11 am and 3 pm. It will focus on the new proposal on EU legislation on Medical Devices and its impact on the compliance path and the CE marking process.
Obelis Scientific Department Officially Launched!
Obelis officially launched a new scientific department. It aims to aid manufacturers and help spread awareness around obligatory compliance issues.